The Hirshberg Foundation is honored to share the stories of pancreatic cancer patients and caregivers from our past three Symposium Patient Panels. These honest and frank discussions give us all […]
New research sheds light on pancreatic cancer biology & role of common p53 mutation
New research from Seed Grant recipient, Marina Pasca di Magliano, PhD, from the University of Michigan has deepened our understanding of the biology of pancreatic cancer, crucial to the development […]
The Hirshberg Foundation funds UCLA School of Nursing Project
In a new study conducted by the UCLA School of Nursing, researchers will assess how supportive care can increase the overall quality of life, and potentially survival rates, in pancreatic […]
New study establishes that ATM activity poses a major barrier to the development of cancer in the pancreas by maintaining genomic stability.
A new study published by our 2014-15 Seed Grant recipient, Yiannis Drosos, PhD has uncovered information that can help diagnose and treat pancreatic cancer tumors.
New two-pronged approach targets pancreatic stellate cells to prevent pancreatic cancer tumor growth
New research conducted at the Ingham Institute for Applied Medical Research in Liverpool, New South Wales, has found a new approach to treating pancreatic cancer. The research, published in Oncotarget, […]
Targeting an enzyme may provide metabolic treatment for pancreatic cancer
A new study released by our 2016-17 Seed Grant Awardee, Nada Kalaany, PhD shows evidence that targeting an enzyme that tumors use to get rid of nitrogen can slow tumor growth. These innovative therapeutic strategies are precisely why our Seed Grant Program is crucial in the fight against pancreatic cancer.